2020 Annual Report - Boston Scientific

WATCHMAN™ customers to a consignment inventory model and transition to the next-generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. Organic2 revenue declined by 6.7 percent in MedSurg , by 13.4 percent in Rhythm and Neuro, and by 13.1 percent in Cardiovascular.3 Outside of our three

  Left, Watchman, Atrial, Left atrial